.png "SkillsPlus International Inc. logo")
 |
| Source: FDA.gov |
The move marks at least the fifth delay for graphic warning health warnings in the United States when counting previously set launch dates of June 18, 2021, Oct. 16, 2021, Jan. 14, 2022, April 14, 2022, and July 13, 2022."
Read the full source article: U.S. Graphic Health Warnings Postponed Again - Tobacco Reporter
Learn more at: Cigarette Labeling and Health Warning Requirements - FDA.gov
Keywords & Phrases:
#FDA #CGMP #GMP
According to the FDA:
"Consumers need to beware of products to lighten or whiten their complexion. These products, which include both injectable skin whitening and skin bleaching products, are potentially unsafe and ineffective, and might contain unknown harmful ingredients or contaminants.
Injectable skin whitening products are marketed for injection into a vein or muscle or under the skin. They are sold online and in some retail outlets and health spas. They often promise to lighten the skin, correct uneven skin tone, and reduce blemishes. Some products even claim to treat conditions such as liver disorders and Parkinson’s disease.
Although the average consumer might not assume so, these products are unapproved new drugs whose sales are not condoned by the U.S. Food and Drug Administration (FDA). The FDA has not approved any injectable drugs for skin whitening or lightening."
Source: Injectable Skin Lightening and Skin Bleaching Products May Be Unsafe - FDA.gov
According to the article:
Read the full source article: Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 - FDA.gov
Intended for California Designated Representative 3PL license applicants and their supervisors.
$525 per student - Buy now! - California Designated Representative 3PL Training Course
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
------
 |
| California Designated Representative 3PL Training Course |
 |
| Current Good Manufacturing Practice Training: A New Generation Series - GMP Online Training Courses |
Source YouTube Video: First rapid concussion blood test approved by FDA - WGN News (video)
According to the article:
"The US Food and Drug Administration on Dec. 22 issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act. The five companies illegally were marketing unapproved CBD products claiming to treat medical conditions, according to the FDA."
Read the full source article: FDA sends CBD warning letters to five companies - Food Business News
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructorsAccording to the news release:
The "U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older."
Read the full news release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine - FDA. gov
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
----
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructorsAccording to the news release:
"Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19. The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test, a type of test that runs a liquid sample along a surface with reactive molecules. The test detects fragments of proteins of the SARS-CoV-2 virus from a nasal swab sample from any individual 2 years of age or older.
“Today’s authorization is a major milestone in diagnostic testing for COVID-19. By authorizing a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes,” said FDA Commissioner Stephen M. Hahn, M.D. “As we continue to authorize additional tests for home use, we are helping expand Americans’ access to testing, reducing the burden on laboratories and test supplies, and giving Americans more testing options from the comfort and safety of their own homes.” "
Read the full news release:
Read the full source article: FDA Is Hosting A Conference On CBD, Sex And Gender This Week - Marijuana Moment
According to the article ...
"As the federal government continues to develop regulations around CBD, the Food and Drug Administration (FDA) will host a public conference on Thursday to highlight how the cannabinoid’s use and effects may differ based on sex and gender.
The daylong meeting, organized by FDA’s Office of Women’s Health, will include presentations on “sex differences in the effects of CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research and evaluation,” according to an agency description."
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
------
According to the update:
"To assist the food industry as it navigates changes to operations related to COVID-19, the FDA has teamed up with OSHA to develop the “Employee Health and Food Safety Checklist for Human and Animal Food Operations During the COVID-19 Pandemic.” The checklist pulls from existing guidance provided by the FDA, CDC, and OSHA and serves as a quick reference to help the food industry assess employee health, social distancing, and food safety within workplaces as operations may be impacted by COVID-19.
The checklist is broken into two distinct sections. The first section focuses on employee health, screening, and operation configuration for social distancing to prevent or minimize the spread of COVID-19 based on guidelines provided by CDC and OSHA. The second section highlights food safety requirements, found in existing regulations, that can help the food industry assess the potential impact of COVID-19-related operational changes on food safety practices. Some operational changes that could impact food safety include closures, changes among food safety staff, or changes to suppliers or ingredients."
Read the full source article:
FDA and OSHA Team Up to Publish Checklist to Assist Food Industry During COVID-19 | FDA .gov
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
"Today, we are providing updates on our efforts in this area, including several new steps in areas of education, research and enforcement with the ultimate goal of continuing to protect the public health and working to provide market clarity."Read the full FDA Statement: FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity - FDA.gov
"While the process remains ongoing, the agency announced that it is actively exploring pathways to allow for the marketing of cannabidiol as a dietary supplement and is developing enforcement discretion guidance. It will also be reopening a public docket to solicit additional scientific information about the risk and benefits of the cannabis compound."Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
 |
| FDA GMP Training - online training classes by SkillsPlus Intl Inc. |
|
| FDA cGMP QSR GMP online training courses by SkillsPlus Intl Inc. |
 |
| FDA cGMP QSR GMP Online Training Courses by SkillsPlus International Inc. |
Posts
All Comments
